BVF Inc’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,563,748
Closed -$70.5M 76
2023
Q3
$70.5M Hold
10,563,748
1.9% 12
2023
Q2
$95.7M Hold
10,563,748
2.67% 9
2023
Q1
$76.8M Buy
10,563,748
+1,386,000
+15% +$10.3M 2.81% 10
2022
Q4
$66.9M Buy
9,177,748
+3,587,700
+64% +$26.6M 2.82% 9
2022
Q3
$43.2M Buy
5,590,048
+2,222,222
+66% +$18.9M 1.79% 19
2022
Q2
$22.9M Hold
3,367,826
1.11% 29
2022
Q1
$26.8M Buy
3,367,826
+447,300
+15% +$2.84M 1.07% 30
2021
Q4
$16.4M Buy
2,920,526
+148,300
+5% +$1.11M 0.59% 44
2021
Q3
$21.3M Hold
2,772,226
0.83% 35
2021
Q2
$28.5M Buy
2,772,226
+2,000,000
+259% +$20.3M 1.07% 25
2021
Q1
$8.12M Sell
772,226
-182,770
-19% -$2.48M 0.3% 53
2020
Q4
$13.3M Sell
954,996
-45,004
-5% -$625K 0.52% 39
2020
Q3
$14.4M Buy
+1,000,000
New +$13.6M 0.78% 38

Other funds holding PNT

BVF Inc's PNT Position: Q4 2023 in Review

BVF Inc sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 10,563,748 shares — an estimated $70.5M sold.

BVF Inc first reported a position in PNT in Q3 2020 and held it in 13 quarters. The position peaked at $95.7M in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • BVF Inc reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • BVF Inc sold 10,563,748 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $70.5M.
  • BVF Inc first reported a position in POINT Biopharma Global Inc. Common Stock in Q3 2020 and held it in 13 quarters.
  • BVF Inc's POINT Biopharma Global Inc. Common Stock position peaked at $95.7M in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on BVF Inc's 13F filing for Q4 2023, filed 14 Feb 2024.